NAP1 switches from an activator to a limiter of interferon induction by trapping TBK1 in condensates
- Damien Glon
- Quentin Riller
- Lucía Álvarez
- Louise Gioja
- Frédéric Rivière
- Benjamin Léonardon
- Zackie Aktary
- Ariane Guillemot
- Laïla Sago
- Olivier Pellé
- Nhat-Duong Ho
- Karine Brochard
- Camille Brunaud
- Luís Seabra
- Gillian I. Rice
- Vincent Bondet
- Darragh Duffy
- Brigitte Bader-Meunier
- Marie-Louise Frémond
- Alice Lepelley
- Yanick J. Crow
- Maud Tusseau
- Alexandre Belot
- Cécile Lagaudrière-Gesbert
- Frédéric Rieux-Laucat
- Yves Gaudin
2026-08-19
TBK1 kinase is a central regulator of type I IFN production. Upon activation of the IFN-β induction pathway, TBK1-adaptor proteins (NAP1, SINTBAD, TANK) form liquid condensates. We show that NAP1 condensates concentrate TBK1. Using NAP1 KO cell lines, we demonstrate that NAP1 exerts a dual effect on TBK1 activity. Initially, NAP1 binds TBK1 and increases its activity, promoting IFN pathway activation. Subsequently, TBK1-mediated phosphorylation of NAP1 induces the formation of condensates. These NAP1 condensates concentrate both TBK1 and the phosphatase PP2A, which dephosphorylates and consequently deactivates TBK1, thus limiting IFN induction. Additionally, in patients with lupus or interferonopathies, we identify NAP1 variants unable to form condensates upon danger signal exposure, which sustain TBK1 activation without limiting its activity. This study reveals a mode of regulating a signaling pathway through condensate formation and provides a potential molecular explanation for immune dysregulation associated with NAP1 variants in certain patients with interferonopathies.